When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PHG - Arrowhead reports encouraging data on cardiometabolic candidates ARO-APOC3 and ARO-ANG3
Koninklijke Philips N.V. NY Registry Shares
Arrowhead Pharmaceuticals (NASDAQ:ARWR)announces positive new Phase 1/2 clinical data on two RNAi-based cardiometabolic candidates, ARO-APOC3 targeting apolipoprotein C-III (APOC3) being developed as a treatment for patients with hypertriglyceridemia, and ARO-ANG3 targeting angiopoietin like protein 3 (ANGPTL3) for treatment for mixed dyslipidemias.
More news on: Arrowhead Pharmaceuticals, Inc., MyoKardia, Inc., Johnson & Johnson, Healthcare stocks news,